Pulmonology

Papers
(The H4-Index of Pulmonology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Disease burden, comorbidities and antecedents of chronic cough phenotypes in Australian adults346
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study. Authors’ reply159
Development and evaluation of spirometry reference equations at high altitude60
Complete response to mTOR inhibitor following JAKi failure in severe pulmonary sarcoidosis: Authors’ reply53
The Legend score synthesizes Wells, PERC, Geneva, D-dimer and predicts acute pulmonary embolism prior to imaging tests51
“Alveolar stem cell exhaustion, fibrosis and bronchiolar proliferation” related entities. A narrative review49
Smoking exposure trajectories and pulmonary function in early adulthood in a Brazilian cohort46
In-hospital mortality of high-risk pulmonary embolism: a nationwide population-based cohort study in Portugal from 2010 to 201844
Weaning from tracheostomy: Trend of decannulation rate over two decades in a respiratory rehabilitation centre44
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study40
Issue 3—The occupational burden of respiratory diseases, an update38
High-dose inhaled NO for the prevention of nosocomial pneumonia after cardiac surgery under cardiopulmonary bypass: A proof-of-concept prospective randomised study36
Low tumour interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study36
COPD: How can evidence from randomised controlled trials apply to patients treated in everyday clinical practice?34
COVID-19 pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU. Authors’ reply33
The Vacinómetro® initiative: an eleven-year monitorization of influenza vaccination coverage rates among risk groups in Portugal32
Correspondence: Exploring the role of nasal high flow therapy in enhancing exercise tolerance in COPD patients30
“ Gallia est omnis divisa in partes tres ”: Is it time to divide Pleuroparenchymal Fibroelastosis in three different forms?29
Noninvasive ventilatory support in morbid obesity29
Assisted mobilisation in critical patients with COVID-1927
The rise of old villains: the vaccination downfall worldwide26
Assessment of the underreporting of rhinitis in patients with asthma: A MASK-air® real-world study25
The utility of dynamic chest radiography in patients with asthma, COPD, COVID-19 and ILD: A pilot study25
Smoking-attributable mortality in Portugal and its regions in 201924
0.093930006027222